Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT
NCT00311038Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of landiolol in coronary artery disease (CAD), sponsored by Ono Pharmaceutical. Primary endpoints: Heart Rate, Image Quality and 1 more. Started Apr 2006; status: completed.
02
Drugs
landiolol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00311038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311038.